Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
13F holders, Q4 2025 (December 31)9holders +3
3new positions
0sold out
$1.93avg. 13F price*
At the end of Q4 2025, 9 institutions reported holding Bridgebio Pharma Inc. (bbio 2.5 03/15/27) in their 13F filings, up 3 from Q3 2025. 3 opened new positions and 0 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($6.0M), State of Wisconsin Investment Board ($5.7M) and Bank of New York Mellon Corp ($566K).
- Company
- Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
- CUSIP
- 10806XAB8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $6.1M |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 3,215,000 shares bought and 291,354 shares sold, net +2,923,646 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | New | 3,180,000 | $6.0M |
| State of Wisconsin Investment Board | 0.01% | No change | 3,000,000 | $5.7M |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $566K |
| Nomura Holdings Inc. | 0.00% | Reduce -98.9% | 3,348 | $256K |
| NewEdge Advisors, LLC | 0.00% | New | 19,000 | $36K |
| &partners | 0.00% | New | 16,000 | $30K |
| Traub Capital Management LLC | 0.02% | No change | 10,000 | $19K |
| Jones Financial Companies LLLP | 0.00% | No change | 1,000 | $2K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,000 | $2K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.5 03/15/27) the manager owns.